Skip to content
value.today

GRO Biosciences Inc.

🇺🇸 Allston, Massachusetts, USABiotechnologyFounded 2016
Total raised
$33 M
3 rounds on record
Latest round
$27 M
Jul 2024
First round on record
Aug 2017
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GRO Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$27 MNo. 3$10 to $50 million

GRO Biosciences Inc.: Raise no. 3, Jul 2024

Investors in this round

13 investors had bought by the notice of Jul 25, 2024: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $60 M offered; $33 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel J Mandell · Executive Officer, Director
  • Tracey J Lodie · Executive Officer
  • Bruce J Beutel · Director
  • Dan J Becker · Director
  • Kevin J Bitterman · Director
  • Ming J Fang · Director
  • Rakhshita J Dhar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel J Mandell, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 25, 2024. Read the notice at the SEC.

equitySEC
Mar 2019$4 MNo. 2$2 to $10 million

GRO Biosciences Inc.: Raise no. 2, Mar 2019

Investors in this round

10 investors had bought by the notice of Mar 22, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Mandell · Executive Officer, Director
  • Christopher Gregg · Director
  • Geoffrey Smith · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Mandell, Ceo. Source: SEC Form D, newest notice filed Mar 22, 2019. Read the notice at the SEC.

equitySEC
Aug 2017$2 MNo. 1$2 to $10 million

GRO Biosciences Inc.: Raise no. 1, Aug 2017

Investors in this round

8 investors had bought by the notice of Sep 21, 2017: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel J Mandell · Executive Officer, Director
  • Christopher J Gregg · Director
  • Geoffrey J Smith · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel J. Mandell, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 21, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • GRO Biosciences Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2024

That is all the official record says: GRO Biosciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of GRO Biosciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GRO Biosciences Inc.
NameRoleNamed in
Daniel J MandellExecutive officerJul 2024
Tracey J LodieExecutive officerJul 2024
Daniel MandellExecutive officerMar 2019
Dainel MandellExecutive officerAug 2017
Bruce J BeutelDirectorJul 2024
Dan J BeckerDirectorJul 2024
Daniel J MandellDirectorJul 2024
Kevin J BittermanDirectorJul 2024
Ming J FangDirectorJul 2024
Rakhshita J DharDirectorJul 2024
Christopher GreggDirectorMar 2019
Daniel MandellDirectorMar 2019
Geoffrey SmithDirectorMar 2019
Christopher J GreggDirectorSep 2017
Geoffrey J SmithDirectorSep 2017
Dainel MandellDirectorAug 2017